VGT icon

Vanguard Information Technology ETF

627.47 USD
+9.31
1.51%
At close Jan 17, 4:00 PM EST
After hours
627.75
+0.28
0.04%
1 day
1.51%
5 days
4.05%
1 month
-2.56%
3 months
4.32%
6 months
7.68%
Year to date
0.99%
1 year
30.79%
5 years
141.68%
10 years
513.42%
0
Funds holding %
of 6,823 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

286% more call options, than puts

Call options by funds: $502M | Put options by funds: $130M

92% more first-time investments, than exits

New positions opened: 136 | Existing positions closed: 71

3% more funds holding

Funds holding: 1,502 [Q2] → 1,543 (+41) [Q3]

9% more repeat investments, than reductions

Existing positions increased: 536 | Existing positions reduced: 493

0% less capital invested

Capital invested by funds: $30.9B [Q2] → $30.8B (-$133M) [Q3]

3.37% less ownership

Funds ownership: 42.83% [Q2] → 39.46% (-3.37%) [Q3]

12% less funds holding in top 10

Funds holding in top 10: 104 [Q2] → 92 (-12) [Q3]

Research analyst outlook

We haven’t received any recent analyst ratings for VGT.

Financial journalist opinion

Based on 13 articles about VGT published over the past 30 days

Positive
Seeking Alpha
11 hours ago
VGT: The Only One To Hold
The technology sector, despite slowing earnings growth, remains attractive due to solid future earnings expectations and AI potential, with Vanguard Information Technology Index Fund ETF Shares (VGT) being a top choice for exposure. With nearly $100 billion in assets, VGT offers broad exposure to tech stocks, including small and mid-caps, and has a low expense ratio of 0.1%. VGT's top holdings are concentrated, but that is a feature in similar funds like XLK and IYW.
VGT: The Only One To Hold
Neutral
24/7 Wall Street
22 hours ago
VGT vs VOO: Which Vanguard ETF Is the Better Buy Today?
Vanguard is one of the gold standards when it comes to low-cost exchange-traded fund (ETF) options.
VGT vs VOO: Which Vanguard ETF Is the Better Buy Today?
Positive
The Motley Fool
23 hours ago
3 Vanguard ETFs to Buy With $2,000 and Hold Forever
If you're looking for a more passive approach to investing but don't want to sacrifice your potential gains, there's an obvious solution -- exchange-traded funds, or ETFs. These of course are pre-selected baskets of stocks bought and sold as a group.
3 Vanguard ETFs to Buy With $2,000 and Hold Forever
Positive
The Motley Fool
1 week ago
1 Vanguard Index Fund to Buy Before It Soars on AI Tailwinds in 2025, According to a Wall Street Analyst
The S&P 500 entered its current bull market in October 2022 and has since advanced 65%, led by a 130% gain in the technology sector. But equity analyst Dan Ives at Wedbush says the bull market will run for another two to three years, and he believes technology stocks could soar 25% in 2025.
1 Vanguard Index Fund to Buy Before It Soars on AI Tailwinds in 2025, According to a Wall Street Analyst
Positive
The Motley Fool
1 week ago
3 Unstoppable Growth ETFs to Stock Up On in 2025 and Beyond
Investing in a growth ETF can be a smart way to build your portfolio with minimal effort. A growth ETF is a collection of stocks that have the potential to earn higher-than-average returns, grouped together into a single investment.
3 Unstoppable Growth ETFs to Stock Up On in 2025 and Beyond
Neutral
Business Wire
1 week ago
Vergent Bioscience Receives FDA Fast Track Designation for Abenacianine for Injection (VGT-309) to Help Surgeons Visualize Tumors in the Lung During Surgery
MINNEAPOLIS--(BUSINESS WIRE)--Vergent Bioscience, a clinical-stage biotechnology company developing tumor-targeted imaging agents, announced that the U.S. Food & Drug Administration (FDA) has granted Fast Track designation for the company's novel, investigational tumor-targeted fluorescent imaging agent, abenacianine for injection (VGT-309), as an adjunct for the intraoperative visualization of primary lung cancer, other pulmonary lesions, cancer containing lymph nodes, and positive surgica.
Vergent Bioscience Receives FDA Fast Track Designation for Abenacianine for Injection (VGT-309) to Help Surgeons Visualize Tumors in the Lung During Surgery
Positive
The Motley Fool
2 weeks ago
1 Vanguard ETF I'm Buying in 2025 and Holding Forever
The right investment has the power to transform your portfolio, and exchange-traded funds (ETFs) can be a smart way to supercharge your savings with very little effort.
1 Vanguard ETF I'm Buying in 2025 and Holding Forever
Neutral
The Motley Fool
2 weeks ago
1 Vanguard ETF to Ride the Agentic and Physical AI Revolution in 2025
The technology sector is witnessing the rise of two transformative subsectors that are reshaping the future. Agentic AI, the next evolution in artificial intelligence (AI), empowers machines to make autonomous decisions and proactively complete complex tasks without constant human oversight.
1 Vanguard ETF to Ride the Agentic and Physical AI Revolution in 2025
Negative
Seeking Alpha
3 weeks ago
VGT: Promising Long-Term Outlook With Short-Term Uncertainty
The tech sector thrived in 2024, with standout performances from Apple, Microsoft, and Nvidia, but potential volatility looms ahead. VGT is highly concentrated in its top three holdings, which poses risks despite their strong performance this year. VGT is well-rounded compared to peers, but currently overbought; a correction would make it a safer investment.
VGT: Promising Long-Term Outlook With Short-Term Uncertainty
Positive
The Motley Fool
3 weeks ago
3 Unstoppable Growth ETFs to Stock Up On in 2025
Investing in the stock market can help you build long-term wealth, but the investments you choose can make or break your earning potential.
3 Unstoppable Growth ETFs to Stock Up On in 2025
Charts implemented using Lightweight Charts™